Around 200 Lives Saved by HPV Vaccine in England
Thursday, June 18, 2026
hpv
cervicalcancer
vaccine
prevention
publichealth
screening
england
immunization
hpvvaccine
healthpolicy
A groundbreaking study funded by Cancer Research UK and led by Queen Mary University of London reveals that approximately 200 lives have been saved in England due to the human papillomavirus (HPV) vaccine, with more lives expected to be protected as vaccinated individuals age. The study, published in The Lancet, highlights the vaccine’s powerful role in preventing cervical cancer and moving toward its eradication nationwide.
Children vaccinated at ages 12 to 13 face an almost zero risk of dying from cervical cancer before turning 30.